Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2019

01-03-2019 | Images in Nephrology

Left-sided inferior vena cava with nutcracker syndrome

Authors: Yasuhiro Ueda, Hayato Aoyagi, Takayuki Okamoto

Published in: Clinical and Experimental Nephrology | Issue 3/2019

Login to get access

Abstract

Left-sided inferior vena cava (IVC) is a rare malformation of IVC. We report an 11-year-old boy with hematuria and left lower back pain due to compression of the left-sided IVC between the aorta and the superior mesenteric artery. Ultrasonography and magnetic resonance imaging clearly revealed this anatomic anomaly.
Literature
1.
go back to reference Mayo J, Gray R, St. Louis E, Grosman H, McLoughlin M, Wise D. Anomalies of the inferior vena cava. AJR. 1983;140:339–45.CrossRefPubMed Mayo J, Gray R, St. Louis E, Grosman H, McLoughlin M, Wise D. Anomalies of the inferior vena cava. AJR. 1983;140:339–45.CrossRefPubMed
2.
go back to reference Bass JE, Redwine MD, Kramer LA, Huynh PT, Harris JH Jr. Spectrum of congenital anomalies of the inferior vena cava: cross-sectional imaging findings. Radiographics. 2000;20:639–52.CrossRefPubMed Bass JE, Redwine MD, Kramer LA, Huynh PT, Harris JH Jr. Spectrum of congenital anomalies of the inferior vena cava: cross-sectional imaging findings. Radiographics. 2000;20:639–52.CrossRefPubMed
Metadata
Title
Left-sided inferior vena cava with nutcracker syndrome
Authors
Yasuhiro Ueda
Hayato Aoyagi
Takayuki Okamoto
Publication date
01-03-2019
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 3/2019
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1636-5

Other articles of this Issue 3/2019

Clinical and Experimental Nephrology 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine